An appeals court that POM Wonderful cannot advertise that its juices treat or prevent heart disease unless it can prove that the assertions are true.» Read More
The results of the Robert Wood Johnson Foundation's annual County Health Rankings are out, and offer a glimpse at the many ways one can measure health and quality of life.
Sixty percent of uninsured people remain unaware that next Monday is the deadline to enroll in some kind of health plan.
The Obama administration is granting an extension to people who say they are unable to enroll in the new health-care program by Monday's deadline.
Two recent Obamacare battles show politicians don’t understand the first thing about taxes, yet they're using them as a weapon, says Jake Novak.
New York and Kentucky seem to be doing more than their fair share of the work in signing up the uninsured in Obamacare.
A look at the winners and losers created by the botched rollout of many Obamacare health exchanges.
A serious threat from an antibiotic-resistant superbug is putting the nation's children at serious risk with no drugs to fight it, researchers say.
Government Obamacare exchanges lag far behind their targets for enrolling young adults, but an online broker is excelling at signing up those folks.
The Supreme Court will consider whether businesses can object to a law that requires employers to provide insurance that covers birth control.
A high-priced drug sold by Gilead Sciences is under lawmakers' scrutiny. But one analyst says there's a bigger problem.
Sherpaa, a medical start-up, is making strides, including gaining financial support from David Karp, founder of Tumblr, now part of Yahoo, the Wall Street Journal reported.
The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.
People who already started the process of signing up for insurance under the Affordable Care Act may get a little more time to finish enrolling.
Biogen CEO George Scangos talks about future growth opportunities at the company on CNBC's "Fast Money."
If the main goal of the Affordable Care Act is to insure Americans, why is the administration not asking applicants whether they were insured?
Biotechs drop on reports Rep. Waxman has sent a letter to Gilead's CEO asking him to justify the price of Hepatitis C drug Sovaldi.
As trust beneficiaries feel the bite of Obamacare's 3.8 percent investment income tax and higher rates, estate planners look to reduce it.
Oregon's botched Obamacare insurance exchange lost its second director, according to The Oregonian.
As Americans rush to sign up for Obamacare plans before the March 31 deadline, investors have turned bullish on health insurers.
Almost half of Americans ages 40 to 75 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines.
Get the best of CNBC in your inbox